1. 문희주, 권혁한. 기본면역학. 서울:대학서림. 1996:20-8.

2. 강재성 외 29명. 세포분자면역학. 서울:범문사. 2002:3-38, 102-21.(450)

3. 이현철 외 14명. 면역 및 알레르기학. 광주:전남대학교 출판부. 1999:1-7.

4. 김세종. 면역학 길라잡이. 서울:고려의학. 2000: 15-8.

5. 洪元植 編. 精校黃帝內經. 서울:東洋醫學硏究院. 1981:123-24, 285.

6. 許浚. 東醫寶鑑. 서울:南山堂. 2004:342, 443, 450.

7. 朱震亨. 丹溪心法附餘. 서울:大成文化社. 1999: 697.

8. 洪律憙. 補中益氣湯과 香砂六君子湯의 倂用投與가 癌細胞를 接種한 생쥐의 細胞性 免疫에 미치는 영향. 서울:동국대학교 대학원. 1994.

9. 裵元永, 高炯均, 金昌煥. 黃芪 藥鍼이 MTX를 投與한 생쥐의 免疫反應에 미치는 影響. 大韓鍼灸學會. 1994;11(1):49-66.

10. 崔舜皓. 究原心賢丸이 methotrexate로 유발된 흰쥐의 免疫機能低下에 미치는 影響. 대구: 대구한의대학교 대학원. 2005.

11. 서설. 기초임상면역학. 서울:고려의학. 2001: 10-21, 66-9, 132-49, 215-21.

12. 韓醫科大學本草學編纂委員會. 本草學. 서울:永林社. 2004:204, 224, 599, 610, 621, 633, 635, 690.

13. Artym J, Zimecki M, Kruzel ML. Effect of lactoferrin on the methotrexate-induced suppr- ession of the cellular and humoral immune response in mice. Anticancer Res. 2004;24(6) :3831-6.

14. Cetiner M, Sener G, Sehirli AO, Eksioglu- Demiralp E, Ercan F, Sirvanci S, et al. Taurine protects against methotrexate- induced toxicity and inhibits leukocyte death. Toxicol Appl Pharmacol (in press). 2005.

15. Grossie VB Jr, Ho DH, Loo TL . Effect of malnutrition on methotrexate toxicity and tissue levels of dihydrofolate reductase in the rat. Cancer Treat Rep. 1982;66(1):85-9.

16. Lee YS, Han OK, Park CW, Suh SI, Shin SW, Yang CH, Jeon TW, Lee ES, Kim KJ, Kim SH, Yoo WK, Kim HJ. Immunomodulatory effects of aqueous-extracted Astragali radix in methotrexate-treated mouse spleen cells. J Ethnopharmacol. 2003;84(2-3):193-8.

17. Weaver CH, Clift RA, Deeg HJ, Storb R, Appelbaum FR, Bensinger W, Doney K, Hansen JA, Martin PO, Sanders J. Effect of graft-versus-host disease prophylaxis on relapse in patients transplanted for acute myeloid leukemia. Bone Marrow Transplant. 1994;14 (6):885-93.

18. 韓在敬, 金允姬, 柳同烈. 加味歸茸湯이 생쥐의 免疫細胞에 미치는 影響. 대한한방소아과학회지. 2000;14(2): 47-60.

19. Bohn I. Decrease of B-cells and auto antibodies after low-dose methotrexate. Biomed pharm- acother. 2003;57(7):278-81.

20. Schots R. Van Riet I, Ben Othman T, Trullemans F, De Waele M, Van Camp B. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-idential allogeneic bone marrow transplantation in standard risk adult patients with leukemia. Bone Marrow Transp- lant. 2001;28(10):917-22.

21. Schuerwegh AJ, Van Offel JF, Bridts CH, Stevens WJ, De Clerck LS. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis. J Rheumatol. 2001;28(8):1793-9.

22. Ho VT, Kim HT, Li S, Hochberg EP, Cutler C, Lee SJ, Fisher DC, Milford E, Kao G, Daley H, Levin J, Ng A, Mauch P, Alyea EP, Antin JH, Soiffer RJ.. Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease. Bone Marrow Transplant. 2004;34(11):987-94.

23. Retenaar RJ. Heydendael VM, Van Diepen FN, De Rie MA, Ten Berge IJ. Systemic treat- ment with either cyclosporin A or methotrexate does not influence the T helper1/T helper2 balance in psoriatic patients. J Ciln Immunol. 2004;24(4):361-9.

24. Martin PJ, Rowley SD, Anasetti C, Chauncey TR, Godey T, Petersdorf EW, van Burik JA, Flowers ME, Storb R, Appelbaum FR, Hansen JA. A phase Ⅰ-Ⅱ clinical trial to evaluate removal of CD4+ cells and partial depletion of CD8 cells from donor marrow for HLA- mismatched unrelated recipients. Blood. 1993; 94(7):2192-9.(451)

25. Liang XH, Wang SZ, Mao ZY. Effects of thermochemotherapy on immunologic function of patients with lip cancer. Sichuan Dx Xue Xue Bao Yi Xue Ban. 2004;35(2):220-2.

26. Dayan M, Segal R, Mozes E. Cytokine manip- ulation by methotrexate treatment in murine experimental systemic lupus erythematosus. J Rheumatol. 2001;24(6):1075-82.